The regulation of PBXs and their emerging role in cancer.

Ying Liu, Xiang Ao, Xuehao Zhou, Chengcheng Du, Shouxiang Kuang

Journal of cellular and molecular medicine 2022 Mar

filter terms:

Pre-B-cell leukaemia transcription factor (PBX) proteins are a subfamily of evolutionarily conserved, atypical homeodomain transcription factors that belong to the superfamily of three amino acid loop extension (TALE) homeodomain proteins. Members of the PBX family play crucial roles in regulating multiple pathophysiological processes, such as the development of organs, congenital cardiac defects and carcinogenesis. The dysregulation of PBXs has been shown to be closely associated with many diseases, particularly cancer. However, the detailed mechanisms of PBX dysregulation in cancer progression are still inconclusive. In this review, we summarize the recent advances in the structures, functions and regulatory mechanisms of PBXs, and discuss their underlying mechanisms in cancer progression. We also highlight the great potential of PBXs as biomarkers for the early diagnosis and prognostic evaluation of cancer as well as their therapeutic applications. The information reviewed here may expand researchers' understanding of PBXs and could strengthen the clinical implication of PBXs in cancer treatment. © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Citation

Ying Liu, Xiang Ao, Xuehao Zhou, Chengcheng Du, Shouxiang Kuang. The regulation of PBXs and their emerging role in cancer. Journal of cellular and molecular medicine. 2022 Mar;26(5):1363-1379